Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK.
Int J Gen Med. 2012;5:403-11. doi: 10.2147/IJGM.S25879. Epub 2012 May 4.
Retinol-binding protein 4 (RBP4) is an adipokine identified as a marker of insulin resistance in mice and humans. Protein tyrosine phosphatase 1B (PTP1B) expression levels as well as other genes involved in the endoplasmic reticulum (ER) stress response are increased in adipose tissue of obese, high-fat-diet-fed mice. In this study we investigated if serum and/or adipose tissue RBP4 protein levels and expression levels of PTP1B and other ER stress-response genes are altered in obese and obese/diabetic men resident in northeast Scotland.
WE STUDIED THREE GROUPS OF MALE VOLUNTEERS: (1) normal/overweight (body mass index [BMI] < 30), (2) obese (BMI > 30), and (3) obese/diabetic (BMI > 30) controlling their diabetes either by diet or the antidiabetic drug metformin. We analyzed their serum and adipose tissue RBP4 protein levels as well as adipose tissue mRNA expression of PTP1B, binding immunoglobulin protein (BIP), activated transcription factor 4 (ATF4), and glucose-regulated protein 94 (GRP94) alongside other markers of adiposity (percentage body fat, leptin, cholesterol, triglycerides) and insulin resistance (oral glucose tolerance tests, insulin, homeostatic model assessment-insulin resistance, C-reactive protein, and adiponectin).
We found that obese Scottish subjects had significantly higher serum RBP4 protein levels in comparison to the normal/overweight subjects (P < 0.01). Serum RBP4 levels were normalized in obese/diabetic subjects treated with diet or metformin (P < 0.05). Adipose tissue RBP4 protein levels were comparable between all three groups of subjects as were serum and adipose transthyretin levels. Adipose tissue PTP1B mRNA levels were increased in obese subjects in comparison to normal/overweight subjects (P < 0.05); however diet and/or metformin treatment did not reverse this effect. Adipose tissue BIP, ATF4, and GRP94 expression levels were unchanged in obese and obese/diabetic subjects.
Human obesity results in an increase in serum but not adipose tissue RBP4 protein levels, and these are normalized in obese/diabetic subjects, which exhibit improvements in insulin sensitivity through diet or metformin treatment. However, while adipose tissue PTP1B mRNA levels increase in obese Scottish subjects, these remain high in obese/diabetics on diet or metformin treatment.
视黄醇结合蛋白 4(RBP4)是一种脂肪因子,在小鼠和人类中被鉴定为胰岛素抵抗的标志物。肥胖、高脂肪饮食喂养的小鼠脂肪组织中蛋白酪氨酸磷酸酶 1B(PTP1B)的表达水平以及其他参与内质网(ER)应激反应的基因水平升高。在这项研究中,我们研究了居住在苏格兰东北部的肥胖和肥胖/糖尿病男性的血清和/或脂肪组织 RBP4 蛋白水平以及 PTP1B 和其他 ER 应激反应基因的表达水平是否发生改变。
我们研究了三组男性志愿者:(1)正常/超重(BMI<30),(2)肥胖(BMI>30)和(3)肥胖/糖尿病(BMI>30),通过饮食或抗糖尿病药物二甲双胍控制糖尿病。我们分析了他们的血清和脂肪组织 RBP4 蛋白水平以及脂肪组织中 PTP1B、结合免疫球蛋白蛋白(BIP)、激活转录因子 4(ATF4)和葡萄糖调节蛋白 94(GRP94)的 mRNA 表达,以及其他肥胖标志物(体脂肪百分比、瘦素、胆固醇、甘油三酯)和胰岛素抵抗(口服葡萄糖耐量试验、胰岛素、稳态模型评估-胰岛素抵抗、C-反应蛋白和脂联素)。
我们发现,与正常/超重组相比,苏格兰肥胖男性的血清 RBP4 蛋白水平显著升高(P<0.01)。用饮食或二甲双胍治疗的肥胖/糖尿病患者的血清 RBP4 水平正常化(P<0.05)。三组受试者的脂肪组织 RBP4 蛋白水平相当,血清和脂肪转甲状腺素水平也是如此。与正常/超重组相比,肥胖组的脂肪组织 PTP1B mRNA 水平升高(P<0.05);然而,饮食和/或二甲双胍治疗并不能逆转这种作用。肥胖和肥胖/糖尿病患者的脂肪组织 BIP、ATF4 和 GRP94 表达水平没有变化。
人类肥胖导致血清而非脂肪组织 RBP4 蛋白水平升高,肥胖/糖尿病患者的血清 RBP4 水平正常化,通过饮食或二甲双胍治疗可改善胰岛素敏感性。然而,虽然苏格兰肥胖患者的脂肪组织 PTP1B mRNA 水平升高,但在饮食或二甲双胍治疗的肥胖/糖尿病患者中,这些水平仍然较高。